MEDBOT-B (02252) has announced that the company recently received an official filing notice from the China Securities Regulatory Commission regarding its application for H-share full circulation. This signifies that the company has completed the CSRC filing process for the conversion of a total of 5,989,800 non-listed shares, held by two of its shareholders, into 5,989,800 H-shares on a one-for-one basis. These 5,989,800 H-shares will be listed and traded on the Main Board of The Stock Exchange of Hong Kong following the completion of the conversion process and the granting of listing approval by the Exchange. The notice remains valid for a period of 12 months from the date of approval by the CSRC.